Medicines, Emmi (Careggi): “Monoclonal mepolizumab has changed rare vasculitis treatments”
“Mepolizumab is more effective in achieving and maintaining disease remission and significantly reduces the use of corticosteroids.” This was stated ...
“Mepolizumab is more effective in achieving and maintaining disease remission and significantly reduces the use of corticosteroids.” This was stated ...
"The management of new therapies in the context of clinical trials requires an articulated structure on the part of not ...
© Ruetir 2023. All Rights Reserved.